Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets
Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Helicobacter pylori
, a member of
Epsilonproteobacteria
, is a Gram-negative microaerophilic bacterium that colonizes gastric mucosa of about 50% of the human population. Although most infections caused by
H. pylori
are asymptomatic, the microorganism is strongly associated with serious diseases of the upper gastrointestinal tract su...
Alternative Titles
Full title
Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7666284
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7666284
Other Identifiers
ISSN
0175-7598
E-ISSN
1432-0614
DOI
10.1007/s00253-020-10945-w
